stars 1 stars 2 stars 3

Kinasera is a biotechnology start-up, founded in 2006 as a spin-off of the University of Tartu. It develops and commercializes novel inhibitors of protein kinases (PK) and assay technologies for screening and characterization inhibitors of PK. New biological tools provided by the company rely on the high-affinity bisubstrate-analog inhibitors of PK and constitute fluorescent probes and affinity adsorbents for HTS assays and other methods of analysis of the proteome.

Kinasera Questions

The Kinasera annual revenue was $2.4 million in 2026.

Kinasera is based in Tartu, Tartu.

The NAICS codes for Kinasera are [5417, 54171, 54, 541, 541713].

The SIC codes for Kinasera are [873, 87].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users